Inventor · disambiguated record
David Hepworth
Also filed as: HEPWORTH DAVID
29 granted patents·9 pending applications·332 citations·filing 1998–2025
96Inventor score
Top patents by PatentIndex Score
38 records- 0197US11702424B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2020·Granted Jul 18, 2023·4 cites·8 claims
- 0295US9879022B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2016·Granted Jan 30, 2018·19 cites·22 claims
- 0395US9458168B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2015·Granted Oct 4, 2016·17 cites·44 claims
- 0494US6630504B2Phenoxyphenylheterocyclyl derivatives as SSRIsPFIZER·Filed 2001·Granted Oct 7, 2003·57 cites·16 claims
- 0593US6448293B1Diphenyl ether compounds useful in therapyPFIZER·Filed 2001·Granted Sep 10, 2002·35 cites·28 claims
- 0691US11702405B2Chemical compoundsPFIZER·Filed 2021·Granted Jul 18, 2023·2 cites·14 claims
- 0791US10793579B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2019·Granted Oct 6, 2020·3 cites·8 claims
- 0891US6380394B1Epothilone analogsSCRIPPS RESEARCH INST·Filed 1998·Granted Apr 30, 2002·107 cites·10 claims
- 0986US10329302B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2018·Granted Jun 25, 2019·3 cites·2 claims
- 1086US6914160B1Oxytocin inhibitorsPFIZER·Filed 2003·Granted Jul 5, 2005·32 cites·13 claims
- 1185US12202836B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2023·Granted Jan 21, 2025·0 cites·14 claims
- 1285US11014908B2Chemical compoundsPFIZER·Filed 2019·Granted May 25, 2021·3 cites·28 claims
- 1385US10174000B2Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulatorsPFIZER·Filed 2016·Granted Jan 8, 2019·5 cites·10 claims
- 1484US9440949B2Diacylglycerol acyltransferase 2 inhibitorsPFIZER·Filed 2015·Granted Sep 13, 2016·5 cites·11 claims
- 1583US8841314B22-ThiopyrimidinonesPFIZER·Filed 2013·Granted Sep 23, 2014·4 cites·6 claims
- 1680US7576081B2Morpholine dopamine agonistsPFIZER·Filed 2006·Granted Aug 18, 2009·2 cites·3 claims
- 1779US10316018B2Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulatorsPFIZER·Filed 2018·Granted Jun 11, 2019·2 cites·4 claims
- 1879US9296745B2Diacylglycerol acyltransferase 2 inhibitorsPFIZER·Filed 2013·Granted Mar 29, 2016·6 cites·17 claims
- 1979US8835449B22-thiopyrimidinonesCONN EDWARD L·Filed 2012·Granted Sep 16, 2014·5 cites·5 claims
- 2078US7649002B2(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonistsPFIZER·Filed 2005·Granted Jan 19, 2010·4 cites·42 claims
- 2176US12103921B2Chemical compoundsPFIZER·Filed 2023·Granted Oct 1, 2024·0 cites·5 claims
- 2275US9399626B22-thiopyrimidinonesPFIZER·Filed 2014·Granted Jul 26, 2016·2 cites·6 claims
- 2375US7323462B2Morpholine dopamine agonistsPFIZER·Filed 2003·Granted Jan 29, 2008·5 cites·1 claims
- 2471US6610747B2Phenoxybenzylamine derivatives as SSRIsPFIZER·Filed 2001·Granted Aug 26, 2003·6 cites·39 claims
- 2569US7902188B2Morpholine dopamine agonistsPFIZER·Filed 2009·Granted Mar 8, 2011·0 cites·2 claims
- 2664US7129234B2Phenyl heterocyclyl ethersPFIZER·Filed 2003·Granted Oct 31, 2006·2 cites·18 claims
- 2764US6800652B2Diaryl compoundsPFIZER·Filed 2003·Granted Oct 5, 2004·2 cites·11 claims
- 2857US2009005354A1New Amino Derivatives and Their Use as PharmaceuticalsPFIZER·Filed 2008·Application pending·0 cites
- 2953US9873673B22-thiopyrimidinonesPFIZER·Filed 2016·Granted Jan 23, 2018·0 cites·11 claims
- 3050US2005026920A1Diaryl compoundsPFIZER·Filed 2004·Application pending·0 cites
- 3150US2025320213A1Nitrogen-Containing Heterocyclic CompoundsPFIZER·Filed 2025·Application pending·0 cites
- 3249US2005288270A1New aminopyridine derivatives and their use as pharmaceuticalsPFIZER·Filed 2005·Application pending·0 cites
- 3346US2004180941A13-(1-[3-(1,3-Benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as NEP inhibitorsPFIZER·Filed 2004·Application pending·0 cites
- 3445US2003207857A1Phenyl heterocyclyl ethersFiled 2002·Application pending·0 cites
- 3544US2005267096A1New indazole and indolone derivatives and their use pharmaceuticalsPFIZER·Filed 2005·Application pending·0 cites
- 3641US2019270778A1Cyclic Peptides As C5a Receptor AntagonistsPFIZER·Filed 2017·Application pending·0 cites
- 3738US10906888B2Pyrimidine carboxamides as inhibitors of Vanin-1 enzymePFIZER·Filed 2017·Granted Feb 2, 2021·0 cites·36 claims
- 3835US2012022058A14,5-dihydro-1h-pyrazole compounds and their pharmaceutical usesARHANCET GRACIELA BARBIERI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Hepworth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →